Drug Information

Drug General Information
Drug ID
D09NVU
Former ID
DIB010959
Drug Name
ZP-1848
Synonyms
Glucagon-like peptide-2 analog (inflammatory bowel disease/ Crohn's disease), Zealand
Indication Inflammatory bowel disease [ICD9: 555, 556; ICD10:K50, K51] Phase 1 [522615]
Company
Zealand Pharma A/S
Target and Pathway
Target(s) Glucagon-like peptide 2 receptor Target Info Modulator [550930]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome G alpha (s) signalling events
Glucagon-type ligand receptors
WikiPathways GPCRs, Class B Secretin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 522615ClinicalTrials.gov (NCT00868660) Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose.
Ref 550930US patent application no. 8,580,918, Peptidic glp-2 agonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.